The global organ preservation market reached a value of US$ 163.5 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 242.6 Million by 2027, exhibiting a CAGR of 6.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Organ preservation refers to the process of preserving healthy organs harvested from the body of donors. The process involves the removal of organs from the donor’s body, storing it for transportation and then transplanting it into the receiver’s body without significant damage. It utilizes various techniques, such as hypothermic machine perfusion, static cold storage (SCS) and normothermic machine perfusion (NMP), to maintain the temperature and oxygen levels of kidneys, liver, lung, heart and other organs. The preservation techniques and solutions used are essential for donor organ quality, which directly influences the morbidity and survival rates of a patient after transplantation.

The increasing prevalence of chronic diseases, along with the growing geriatric population across the globe, are among the key factors driving the growth of the market. Owing to the frequent occurrences of organ failures due to diabetes, cardiovascular disorders (CVDs), obesity, and other such severe medical conditions, there is an increasing need for organ preservation procedures. The advent of innovative and advanced techniques, such as NMP, for organ preservation, is acting as a growth-inducing factor. Such techniques aid in decreasing the probability of reperfusion injury during transplantation and exhibits improved results in cold storage for clinical and experimental studies. Moreover, an increasing number of government and non-government policies and initiatives to promote organ donation are impacting the market growth positively. The rising number of individuals volunteering to donate their organs for transplantation and research purposes are also driving the market further. Other factors, including enhanced research and development (R&D) and significant advancements in the organ preservation infrastructure, are also projected to contribute to the market growth significantly.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global organ preservation market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on preservation solution, organ donation type, technique, organ type and end-user.

Breakup by Preservation Solution:

UW Solution
Custodiol HTK
Perfadex
Others

Breakup by Organ Donation Type:

Living Organ Donation
Deceased Organ Donation

Breakup by Technique:

Static Cold Storage Technique
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others

Breakup by Organ Type:

Kidney
Liver
Lung
Heart
Others

Breakup by End-User:

Hospitals and Clinics
Organ Banks
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being 21st Century Medicine, Biolife Solutions, Bridge to Life Ltd., Bristol-Myers Squibb, Dr. Franz K?hler Chemie GmbH, Essential Pharmaceuticals., Lifeline Scientific, OrganOx, Paragonix Technologies, TransMedics, Waters Medical Systems, Xvivo Perfusion, etc. Key Questions Answered in This Report:

How has the global organ preservation market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global organ preservation market?
What is the breakup of the market based on the preservation solution?
What is the breakup of the market based on the organ donation type?
What is the breakup of the market based on the technique?
What is the breakup of the market based on the organ type?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global organ preservation market and who are the key players?
What is the degree of competition in the industry?